News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A Medicare reimbursement policy proposing that biosimilars have the same pricing code as their reference products could ultimately reduce R&D investment, according to an industry group.
German biopharma apceth has announced a CAR T-cell immunotherapy partnership with the University of Cologne.
We say hello to Baxalta, ask what's the latest in Danaher's $14bn bid for Pall, and look at the latest biotech IPOs in today's Bio-Finance Vision.